|
2010 Book Chapter Drug distribution: is it a more important determinant of drug dosing than clearance?Ulldemolins, M., Roberts, J. A. and Rello, J. (2010). Drug distribution: is it a more important determinant of drug dosing than clearance?. Intensive care medicine: annual update 2010. (pp. 507-516) Brussels, Belgium: Springer. doi: 10.1007/978-1-4419-5562-3_47 |
|
2010 Journal Article Augmented renal clearance: Implications for antibacterial dosing in the critically IllUdy, Andrew A., Roberts, Jason A., Boots, Robert J., Paterson, David L. and Lipman, Jeffrey (2010). Augmented renal clearance: Implications for antibacterial dosing in the critically Ill. Clinical Pharmacokinetics, 49 (1), 1-16. doi: 10.2165/11318140-000000000-00000 |
|
2010 Book Chapter Augmented renal clearance: Unraveling the mystery of elevated antibiotic clearanceUdy, Andrew, Roberts, Jason and Lipman, Jeffrey (2010). Augmented renal clearance: Unraveling the mystery of elevated antibiotic clearance. Yearbook of Intensive Care and Emergency Medicine 2010. (pp. 495-506) edited by J.-L. Vincent. Brussels, Belgium: Springer Verlag. doi: 10.1007/978-3-642-10286-8 |
|
2009 Journal Article Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) studyRanganathan, Dwarakanathan, Varghese, Julie M., Fassett, Robert G., Lipman, Jeffrey, D'Intini, Vincent, Healy, Helen and Roberts, Jason A. (2009). Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study. BMC Nephrology, 10 (1) 42, 1-6. doi: 10.1186/1471-2369-10-42 |
|
2009 Journal Article Clearance of intravenous 5-fluorocytosine during continuous venovenous haemodiafiltration in a patient with hepatosplenic candidiasisRoberts, Jason A., Udy, Andrew A., O'Donoghue, Stephen, Briscoe, Scott, Paterson, David L. and Lipman, Jeffrey (2009). Clearance of intravenous 5-fluorocytosine during continuous venovenous haemodiafiltration in a patient with hepatosplenic candidiasis. International Journal of Antimicrobial Agents, 34 (4), 383-384. doi: 10.1016/j.ijantimicag.2009.05.005 |
|
2009 Journal Article Midazolam metabolism: Implications for individualised dosing?Roberts, Jason A., Coulthard, Mark G., Addison, Russell S., Foot, Carole and Lipman, Jeffrey (2009). Midazolam metabolism: Implications for individualised dosing?. Journal of Pharmacy Practice and Research, 39 (3), 198-201. doi: 10.1002/j.2055-2335.2009.tb00452.x |
|
2009 Journal Article Tissue Distribution of Beta-Lactam Antibiotics: Continuous versus Bolus DosingRoberts, JA and Lipman, J (2009). Tissue Distribution of Beta-Lactam Antibiotics: Continuous versus Bolus Dosing. Journal of Pharmacy Practice and Research, 39 (3), 219-222. doi: 10.1002/j.2055-2335.2009.tb00457.x |
|
2009 Journal Article Dose matters: Dose of antibiotics in the critically ill patient depends on the dose of renal replacement therapyRoberts, Jason A. and Lipman, Jeffrey (2009). Dose matters: Dose of antibiotics in the critically ill patient depends on the dose of renal replacement therapy. Critical Care Medicine, 37 (8), 2491-2492. doi: 10.1097/CCM.0b013e3181aee840 |
|
2009 Journal Article A systematic review on clinical benefits of continuous administration of [beta]-lactam antibioticsRoberts, Jason A., Webb, Steven, Paterson, David, Ho, Kwok M. and Lipman, Jeffrey (2009). A systematic review on clinical benefits of continuous administration of [beta]-lactam antibiotics. Critical Care Medicine, 37 (6), 2071-2078. doi: 10.1097/CCM.0b013e3181a0054d |
|
2009 Journal Article Pharmacokinetic issues for antibiotics in the critically ill patientRoberts, Jason A. and Lipman, Jeffrey (2009). Pharmacokinetic issues for antibiotics in the critically ill patient. Critical Care Medicine, 37 (3), 840-851. doi: 10.1097/CCM.0b013e3181961bff |
|
2009 Journal Article Piperacillin penetration into tissue of critically ill patients with sepsis - Bolus versus continuous administration?Roberts, Jason A., Roberts, Michael S., Robertson, Thomas A., Dalley, Andrew J. and Lipman, Jeffrey (2009). Piperacillin penetration into tissue of critically ill patients with sepsis - Bolus versus continuous administration?. Critical Care Medicine, 37 (3), 926-933. doi: 10.1097/CCM.0b013e3181968e44 |
|
2009 Journal Article Effective dose from cone beam CT examinations in dentistryRoberts, J. A., Drage, N. A., Davies, J. and Thomas, D. W. (2009). Effective dose from cone beam CT examinations in dentistry. British Journal of Radiology, 82 (973), 35-40. doi: 10.1259/bjr/31419627 |
|
2009 Journal Article You only find what you look for: The importance of high creatinine clearance in the critically illUdy, A., Roberts, J. A., Boots, R. J. and Lipman, J. (2009). You only find what you look for: The importance of high creatinine clearance in the critically ill. Anaesthesia and Intensive Care, 37 (1), 11-13. doi: 10.1177/0310057x0903700123 |
|
2009 Conference Publication Using Population Pharmacokinetics To Determine Gentamicin Dosing during Extended Daily Diafiltration in Critically Ill Patients with Acute Kidney InjuryRoberts, J. A., Field, J., Visser, A., Whitbread, R., Lipman, J. and Kirkpatrick, C. (2009). Using Population Pharmacokinetics To Determine Gentamicin Dosing during Extended Daily Diafiltration in Critically Ill Patients with Acute Kidney Injury. 22nd Annual Congress of the European Society of Intensive Care Medicine, Vienna, Austria, 11-14 October 2009. NEW YORK: SPRINGER. |
|
2009 Journal Article Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distributionRoberts, Jason A., Kirkpatrick, Carl M. J., Roberts, Michael S., Robertson, Thomas A., Dalley, Andrew J. and Lipman, Jeffrey (2009). Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. Journal of Antimicrobial Chemotherapy, 64 (1), 142-150. doi: 10.1093/jac/dkp139 |
|
2009 Book Chapter Avoiding toxicity of antibioticsVarghese, Julie M., Roberts, Jason A. and Lipman, Jeffrey (2009). Avoiding toxicity of antibiotics. Patient safety and quality of care in intensive care medicine. (pp. 291-304) edited by Jean-Daniel Chiche and Leanne M. Aitken. Berlin, Germany: Medizinisch Wissenschaftliche Verlagsgesellschaft. |
|
2008 Book Chapter Dose adjustment and pharmacodynamic considerations for antibiotics in severe sepsis and septic ShockUdy, Andrew, Roberts, Jason, Boots, Robert and Lipman, Jeffrey (2008). Dose adjustment and pharmacodynamic considerations for antibiotics in severe sepsis and septic Shock. Sepsis: New Strategies for Management. (pp. 97-136) Berlin, Heidelberg: Springer Berlin Heidelberg. doi: 10.1007/978-3-540-79001-3_8 |
|
2008 Other Outputs Beta-lactam antibiotic dosing in critical care units : bolus vs continuous dosingRoberts, Jason (2008). Beta-lactam antibiotic dosing in critical care units : bolus vs continuous dosing. PhD Thesis, School of Medicine, The University of Queensland. doi: 10.14264/174430 |
|
2008 Journal Article Antibiotic resistance - what's dosing got to do with it?Roberts, Jason A., Kruger, Peter, Paterson, David L. and Lipman, Jeffrey (2008). Antibiotic resistance - what's dosing got to do with it?. Critical Care Medicine, 36 (8), 2433-2440. doi: 10.1097/CCM.0b013e318180fe62 |
|
2008 Journal Article Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?Roberts, Jason A, Lipman, Jeffrey, Blot, Stijn and Rello, Jordi (2008). Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?. Current Opinion in Critical Care, 14 (4), 390-396. doi: 10.1097/MCC.0b013e3283021b3a |
